Gene therapy for carcinoma of the breast: Genetic ablation strategies - sprookjes - yvandenbroek - TriplyDB

Gene therapy for carcinoma of the breast: Genetic ablation strategies

Gene therapy for carcinoma of the breast: Genetic ablation strategies

http://www.wikidata.org/entity/Q24797953

about

Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer Cells Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene.

P2860

Q34487091-EA757979-5550-4CE9-A350-1FC375676441 Q35697542-9B4F7517-398A-4AC8-9075-4BC5C2E50BD9

P2860

Gene therapy for carcinoma of the breast: Genetic ablation strategies

http://www.wikidata.org/entity/Q24797953

description

1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@ast

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@en

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@nl

type

label

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@ast

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@en

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@nl

prefLabel

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@ast

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@en

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@nl

P1433

Q24797953-12E63F89-FC76-4C33-A6D8-CED28615FCCE

P1476

Q24797953-82C547D0-1AD9-45CA-80AE-6411C83DF569

P2093

Q24797953-D76EAEC0-906F-4BB9-9F45-FB0A505F291C

P2860

Q24797953-0264A08A-F44E-4520-8562-584CC8123469

Q24797953-14A312DD-EA3C-423D-843C-B7B87646E3A7

Q24797953-20192A0E-AB46-441E-998D-6C84AD2BCF05

Q24797953-29FABDC8-1D7B-4EBA-B168-31EBFAC6DF59

Q24797953-2DE990DE-694A-400C-BC7F-0170CB70C088

Q24797953-2FEFB05E-FF79-4FB9-B89E-3BBE4BF2F7A1

Q24797953-3188D2B1-2E5C-447B-A5A0-4A42FA8438A2

Q24797953-36AD0B79-A61B-42BC-A000-93DF48640F4C

Q24797953-41000061-C9A1-4E9B-945D-E8E2F0057C8F

Q24797953-4280D2EE-EBAE-47E7-B495-5D6BF698E186

P2888

Q24797953-8E11C003-93BD-453E-B31D-5453A782D6CF

P304

Q24797953-2C9F3793-9972-4A94-A400-05AE4E47FBF8

P31

Q24797953-B247649D-84CC-4978-B05D-D2814C1FAFFF

Q24797953-F5F16E01-CF21-4307-83A9-1BC6892C7CCA

P356

Q24797953-2A5F2A70-7EF7-4FBA-902E-9090D2404723

P407

Q24797953-496F9908-8C21-48ED-A7AD-53F233493551

P433

Q24797953-9FE0A8BD-984A-4A20-96A5-39AF7A7073A7

P478

Q24797953-0BD5A21E-6188-41E1-8E04-0710AB60E5C2

P577

Q24797953-09038092-7A88-43EE-AED1-973A22AB327C

Q24797953-3D88FF4D-502E-43FF-B58A-2D5DE7D264DC

P5875

Q24797953-915BE0EF-5D37-483F-9DE4-EF06295CC340

P6179

Q24797953-A1E202AA-1264-4985-8746-CF49EC4AB207

P698

Q24797953-D81EB7DF-28EF-429A-910E-5369A93EE51F

P921

Q24797953-02243CD4-5975-45DB-8FBF-9880957A3AB3

Q24797953-13F4BCC5-F9F3-41F9-9EC3-C0B52761F550

Q24797953-1989EBDE-A0AC-4D52-81B2-AE0397023A3C

Q24797953-22B7D543-036B-444C-8DF1-5F2F94B4607A

P932

Q24797953-DD502A3A-88D2-487F-80BC-9B8BF1600A4E

P356

P1433

Breast Cancer Research

P1476

Gene therapy for carcinoma of the breast: Genetic ablation strategies

@en

P2093

D T Curiel

http://www.w3.org/2001/XMLSchema#string

P2860

Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization

Suppressor gene alterations in the colorectal adenoma-carcinoma sequence.

Targeted tumor killing via an intracellular antibody against erbB-2.

Antisense RNA to the type I insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo.

Targeted adenoviral vectors for cancer gene therapy (Review).

Chromosomal abnormalities in human breast cancer.

Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast.

Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling.

Somatic genetic changes in human breast cancer.

P2888

P304

45-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR28

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

1999-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12081175

http://www.w3.org/2001/XMLSchema#string

P6179

1002475106

http://www.w3.org/2001/XMLSchema#string

P698

11250692

http://www.w3.org/2001/XMLSchema#string

P921

breast neoplasm

biomedical investigative technique

P932

521213

http://www.w3.org/2001/XMLSchema#string